Molecular Diagnostics

World Market Report

MCP-1226

EXECUTIVE ENGAGEMENTS

POOL

12781
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1534
Interactions with Platform & by Email

PARTICIPANTS

383
Unique # Participated

VALIDATIONS

77
Responses Validated*

COMPANIES

84
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

315

PAGES

880

EDITION

17

PRICE

USD 5600

CODE

MCP-1226


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Molecular Diagnostics Market to Reach $20 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Molecular Diagnostics estimated at US$10.4 Billion in the year 2020, is projected to reach a revised size of US$20 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Reagents & Kits, one of the segments analyzed in the report, is projected to record a 10.4% CAGR and reach US$11.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 8.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.4 Billion, While China is Forecast to Grow at 10.9% CAGR
The Molecular Diagnostics market in the U.S. is estimated at US$4.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 10.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2027.

Software & Service Segment to Record 9.3% CAGR
In the global Software & Service segment, USA, Canada, Japan, China and Europe will drive the 9.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1 Billion in the year 2020 will reach a projected size of US$1.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 9.9% CAGR through the analysis period.

SELECT PLAYERS

Abbott Laboratories; Abbott Molecular; Becton, Dickinson and Company; bioMérieux SA; Cepheid; F. Hoffmann-La Roche Ltd.; Grifols International, S.A.; Hologic, Inc.; QIAGEN N.V.; QuestDiagnostics, Inc.; Siemens Healthcare GmbH; Tecan Group Ltd.; The ELITechGroup; Thermo Fisher Scientific

SEGMENTS

» Component (Reagents & Kits, Instruments, Software & Service) » Technology (PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays, Other Technologies) » Application (Infectious Disease, Oncology Testing, Genetic Testing, Other Applications)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
EXHIBIT: Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As on August 27, 2020
Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
RT-PCR Emerges as the Frontline Technology for Testing COVID-19
Molecular Diagnostic Companies Re-strategize Logistics to Stay at the Top End of the Game
Select Tests Introduced for COVID-19
COVID-19 Plunges Fortunes of Non- COVID Diagnostics
Cancer Testing Dives During First Half of 2020
Myeloproliferative Neoplasm Tests Suffer the Brunt of CoVID-19 Curbs
Labs Embark New Journeys to Retain Overall Volumes
Molecular Diagnostics – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Molecular Diagnostics: An Introduction
Types of Molecular Diagnostics Tests
Market Outlook
Major Growth Drivers
Developing Countries Offer Strong Growth Prospects
PCR Technology Leads the MDx Market
Infectious Diseases: The Largest Application Market
Reagents and Kits Dominate the Molecular Diagnostics Market
Competition
EXHIBIT: Global Molecular Diagnostics Market by Leading Player (2019)
EXHIBIT: Global Molecular Diagnostics Market for Clostridium difficile by Leading Player: 2019
Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Faster Screening Necessitates Point-of-Care Diagnostics for COVID-19
Molecular Diagnostics Market Eyes Transformational Impact of Proactive Diagnostics
Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
Isothermal Amplification: An Alternative to RT-PCR for COVID-19 Testing
Technological Innovations Set to Drive Market Growth
New Product Developments
Digitalization Trends Benefit Growth
Growing Role of Molecular Diagnostics in Personalized Medicine
EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Companion Diagnostics Drive Personalized Medicine
Biomarkers as Companion Diagnostics
Oncology-Based Molecular Diagnostics Lead Growth
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
New Applications Hold Promising Potential
Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
Rising Emphasis on Lab Automation to Augur Well for Market Growth
EXHIBIT: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
Nanotechnology for Molecular Diagnostics
Growing Popularity of Chemo-Sensitivity Testing of CTCs
Genetic Disease Testing Offers Bright Prospects
Genetic Testing to Aid in Personalized Medicine
Pharmacogenomics Development Augurs Growth of Genetic Testing Market
Non-Invasive Prenatal Diagnostics – The Way Ahead
Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
Growing Incidence of Infectious Diseases Spurs Opportunities
EXHIBIT: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
Rising Incidence of Hospital Acquired Infections Propels Market Growth
Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
EXHIBIT: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
EXHIBIT: Number of AIDS-Related Deaths (in Thousands) by Region for 2018
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
Home HIV Testing Emerges as a Lucrative Option
Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
EXHIBIT: Hepatitis B prevalence Worldwide by Region
HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
EXHIBIT: HPV Associated Disorders Market by Indication: 2019
Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
EXHIBIT: Number of New Cervix Uteri Cases in the World by Region (2018)
Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
Rise in Healthcare Expenditure to Drive Growth
EXHIBIT 15: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Aging Population Drives Molecular Diagnostics Market
EXHIBIT: Elderly Healthcare Expenditure as a % of GDP
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Software & Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for In-Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Isothermal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Chips & Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
Market Analytics
Market Overview
EXHIBIT: Healthcare Spending as a % of GDP in the US: 2010-2020
US Emerges as a Major Market for COVID-19 Tests
FDA Plays Instrumental Role in Influx of New Tests
EXHIBIT: EXHIBIT: Cumulative Number of COVI-19 Tests Performed in the US (In ‘000): 31-Mar-30 July 2020
NIH Launches Initiative to Encourage Innovation
Infectious Disease Testing Contributes to High Growth
Ageing Demographics: Major Driving Factor
EXHIBIT: US Elderly Population: Expected Growth Rates Over the Years 2005-2025
Increasing Incidence of Chronic Diseases Drives Focus onto Molecular Diagnostics
Rising Incidence of Cancer: A Major Growth Driver
Molecular Diagnostics Tests Gain Share in STD Testing Domain
HPV Testing Market: A Review
EXHIBIT: Prevalence of HPV in the US by Age
US Personalized Medicine Market to Offer Significant Opportunities
Companion Diagnostics Market in the US
Burgeoning Potential for Genetic Testing
Paradigm Shift amongst Consumers Spurs DTC Genetic Testing Market
USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
JAPAN
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Market Overview
Brief Note on COVID-19 Testing in Japan
Demographics Drive Market Growth
EXHIBIT: Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
Market Analytics
Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
CHINA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Market Overview
COVID-19 Testing: An Overview
HPV Testing in China
Market Analytics
China Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
EUROPE
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Market Overview
COVID-19 Testing Drives Revenue Growth
Covid-19 Testing in the UK
Aging Population: A Prime Growth Driver
Automated Systems Gain Preeminence
Oncology-based Molecular Diagnostics Holds Immense Potential
EXHIBIT: Number of New Cancer Cases in Europe: 2012, 2018, and 2025
EXHIBIT: Distribution of New Cancer Cases by Type in Europe: 2018
HPV Testing in Europe: An Overview
Market Analytics
Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
FRANCE
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
GERMANY
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Market Overview
Healthcare Spending in Asia-Pacific: On the Rise
Market Analytics
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
AUSTRALIA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
INDIA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Market Overview
Laboratories Pick up on Automation
HPV Testing Market: An Overview
EXHIBIT: HPV in India: Breakdown of Type-Distribution and HPV Prevalence
Market Analytics
India Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
LATIN AMERICA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
BRAZIL
Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
MEXICO
Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
MIDDLE EAST
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
ISRAEL
Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027
AFRICA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com